BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8766561)

  • 1. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
    Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
    Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis.
    Kiener HP; Baghestanian M; Dominkus M; Walchshofer S; Ghannadan M; Willheim M; Sillaber C; Graninger WB; Smolen JS; Valent P
    Arthritis Rheum; 1998 Feb; 41(2):233-45. PubMed ID: 9485081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
    Buchner RR; Hugli TE; Ember JA; Morgan EL
    J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.
    Werfel T; Zwirner J; Oppermann M; Sieber A; Begemann G; Drommer W; Kapp A; Götze O
    J Immunol; 1996 Aug; 157(4):1729-35. PubMed ID: 8759762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
    Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
    J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.
    Capron M; Kazatchkine MD; Fischer E; Joseph M; Butterworth AE; Kusnierz JP; Prin L; Papin JP; Capron A
    J Immunol; 1987 Sep; 139(6):2059-65. PubMed ID: 2957447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
    Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the complement anaphylatoxins in the recruitment of eosinophils.
    DiScipio RG; Schraufstatter IU
    Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T cells express the C5a receptor and are chemoattracted to C5a.
    Nataf S; Davoust N; Ames RS; Barnum SR
    J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct amplification of the C5a-receptor pathways in normodense and hypodense eosinophils of patients with atopic dermatitis.
    Czech W; Dichmann S; Herouy Y; Rheinen H; Elsner J; Kapp A; Norgauer J
    Scand J Immunol; 2001 Mar; 53(3):235-9. PubMed ID: 11251879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
    Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
    J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
    Amara U; Kalbitz M; Perl M; Flierl MA; Rittirsch D; Weiss M; Schneider M; Gebhard F; Huber-Lang M
    Shock; 2010 Jun; 33(6):568-75. PubMed ID: 19864971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis.
    Meddows-Taylor S; Pendle S; Tiemessen CT
    J Infect Dis; 2001 Feb; 183(4):662-5. PubMed ID: 11170995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.